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Abstract: Glyphosate, the active ingredient in Roundup®, is the most popular herbicide 
used worldwide. The industry asserts it is minimally toxic to humans, but here we argue 
otherwise. Residues are found in the main foods of the Western diet, comprised primarily 
of sugar, corn, soy and wheat. Glyphosate's inhibition of cytochrome P450 (CYP) enzymes 
is an overlooked component of its toxicity to mammals. CYP enzymes play crucial roles in 
biology, one of which is to detoxify xenobiotics. Thus, glyphosate enhances the damaging 
effects of other food borne chemical residues and environmental toxins. Negative impact 
on the body is insidious and manifests slowly over time as inflammation damages cellular 
systems throughout the body. Here, we show how interference with CYP enzymes acts 
synergistically with disruption of the biosynthesis of aromatic amino acids by gut bacteria, 
as well as impairment in serum sulfate transport. Consequences are most of the diseases 
and conditions associated with a Western diet, which include gastrointestinal disorders, 
obesity, diabetes, heart disease, depression, autism, infertility, cancer and Alzheimer’s 
disease. We explain the documented effects of glyphosate and its ability to induce disease, 
and we show that glyphosate is the “textbook example” of exogenous semiotic entropy: the 
disruption of homeostasis by environmental toxins. 
Keywords: glyphosate; cytochrome P450; eNOS; obesity; cardiovascular disease; cancer; 
colitis; shikimate pathway; gut microbiome; tryptophan; tyrosine; phenylalanine; methionine; 
serotonin; Alzheimer’s disease; Parkinson’s disease; autism; depression 
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1. Introduction 
The foodstuffs of the Western diet, primarily grown by industrial agriculture, are increasingly being 
produced using a two-part system of engineered plant seeds and toxic chemical application. Novel 
bacterial genes are incorporated through genetic engineering, and toxic chemical residues are readily 
taken up by the engineered plants. Research indicates that the new bacterial RNA and DNA present in 
genetically engineered plants, providing chemical herbicide resistance and other traits, have not yet 
fully understood biological effects. This paper however, will only examine the effects of the chemical 
glyphosate, the most popular herbicide on the planet. 
Glyphosate (N-phosphonomethylglycine), the active ingredient in the herbicide Roundup®, is the 
main herbicide in use today in the United States, and increasingly throughout the World, in agriculture 
and in lawn maintenance, especially now that the patent has expired. 80% of genetically modified 
crops, particularly corn, soy, canola, cotton, sugar beets and most recently alfalfa, are specifically 
targeted towards the introduction of genes resistant to glyphosate, the so-called “Roundup Ready® 
feature” In humans, only small amounts (~2%) of ingested glyphosate are metabolized to 
aminomethylphosphonic acid (AMPA), and the rest enters the blood stream and is eventually 
eliminated through the urine [1]. Studies have shown sharp increases in glyphosate contamination in 
streams in the Midwestern United States following the mid 1990s, pointing to its increasing role as the 
herbicide of choice in agriculture [2]. A now common practice of crop desiccation through herbicide 
administration shortly before the harvest assures an increased glyphosate presence in food sources as 
well [3–5]. The industry asserts that glyphosate is nearly nontoxic to mammals [6,7], and therefore  
it is not a problem if glyphosate is ingested in food sources. Acutely, it is claimed to be less toxic than  
aspirin [1,6]. As a consequence, measurement of its presence in food is practically nonexistent. A vocal 
minority of experts believes that glyphosate may instead be much more toxic than is claimed, although 
the effects are only apparent after a considerable time lapse. Thus, while short-term studies in rodents 
have shown no apparent toxicity [8], studies involving life-long exposure in rodents have demonstrated 
liver and kidney dysfunction and a greatly increased risk of cancer, with shortened lifespan [9]. 
Glyphosate’s claimed mechanism of action in plants is the disruption of the shikimate pathway, 
which is involved with the synthesis of the essential aromatic amino acids, phenylalanine, tyrosine, and 
tryptophan [10]. The currently accepted dogma is that glyphosate is not harmful to humans or to any 
mammals because the shikimate pathway is absent in all animals. However, this pathway is present in 
gut bacteria, which play an important and heretofore largely overlooked role in human physiology [11–14] 
through an integrated biosemiotic relationship with the human host. In addition to aiding digestion, the 
gut microbiota synthesize vitamins, detoxify xenobiotics, and participitate in immune system 
homeostasis and gastrointestinal tract permeability [14]. Furthermore, dietary factors modulate the 
microbial composition of the gut [15]. The incidence of inflammatory bowel diseases such as juvenile 
onset Crohn’s disease has increased substantially in the last decade in Western Europe [16] and the 
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United States [17]. It is reasonable to suspect that glyphosate’s impact on gut bacteria may be 
contributing to these diseases and conditions. 
However, the fact that female rats are highly susceptible to mammary tumors following chronic 
exposure to glyphosate [9] suggests that there may be something else going on. Our systematic search 
of the literature has led us to the realization that many of the health problems that appear to be 
associated with a Western diet could be explained by biological disruptions that have already been 
attributed to glyphosate. These include digestive issues, obesity, autism, Alzheimer’s disease, 
depression, Parkinson’s disease, liver diseases, and cancer, among others. While many other 
environmental toxins obviously also contribute to these diseases and conditions, we believe that 
glyphosate may be the most significant environmental toxin, mainly because it is pervasive and it is 
often handled carelessly due to its perceived nontoxicity. In this paper, we will develop the argument 
that the recent alarming increase in all of these health issues can be traced back to a combination of gut 
dysbiosis, impaired sulfate transport, and suppression of the activity of the various members of the 
cytochrome P450 (CYP) family of enzymes. We have found clear evidence that glyphosate disrupts 
gut bacteria and suppresses the CYP enzyme class. The connection to sulfate transport is more indirect, 
but justifiable from basic principles of biophysics. 
In the remainder of this paper, we will first provide evidence from the literature that explains some 
of the ways in which glyphosate adversely affects plants, microbes, amphibians and mammals. Section 3 
will discuss the role that gut dysbiosis, arguably resulting from glyphosate exposure, plays in 
inflammatory bowel disease and its relationship to autism. Section 4 argues that the excess synthesis of 
phenolic compounds associated with glyphosate exposure represents a strategy to compensate for 
impairments in the transport of free sulfate. Section 5 will provide evidence that glyphosate inhibits 
CYP enzymes. Section 6 explains how obesity can arise from depletion of serum tryptophan due to its 
sequestering by macrophages responding to inflammation. Section 7 shows how extreme tryptophan 
depletion can lead to impaired nutrient absorption and anorexia nervosa. Section 8 provides a brief 
review of all the roles played by CYP enzymes in metabolism. Section 9 discusses a likely 
consequence to glyphosate’s disruption of the CYP-analog enzyme, endothelial nitric oxide synthase 
(eNOS). Section 10 shows how glyphosate’s effects could plausibly lead to brain-related disorders 
such as autism, dementia, depression, and Parkinson’s disease. Section 11 mentions several other 
health factors that can potentially be linked to glyphosate, including reproductive issues and cancer. 
Section 12 discusses the available evidence that glyphosate is contaminating our food supplies, 
especially in recent years. Following a discussion section, we sum up our findings with a brief conclusion. 
2. Glyphosate’s Pathological Effects: Controlled Studies 
It is well established that glyphosate, a member of the general class of organophosphates, inhibits 
the enzyme 5-enolpyruvylshikimic acid-3-phosphate synthase (EPSP synthase), the rate-limiting step 
in the synthesis of aromatic amino acids in the shikimate pathway in plants [18]. This pathway, while 
not present in mammals, is present in algae, Archaea, bacteria, fungi, and prokaryotes, and unicellular 
eukaryotic organisms [19]. Indeed, corn and soy crops have both been shown to accumulate excess 
shikimate in response to glyphosate exposure [20]. However, a study comparing glyphosate-tolerant 
and glyphosate-sensitive carrot cell lines identified several pathologies beyond the inhibition of 
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aromatic amino acids following glyphosate exposure [21]. It was determined that, in addition to 
abnormally low levels of tryptophan, phenylalanine and tyrosine, the glyphosate-sensitive cells also 
had 50 to 65% reduced levels of serine, glycine and methionine. The reduction in methionine can have 
many adverse consequences, as methionine is an essential sulfur-containing amino acid that has to be 
supplied from the diet. In addition, there was evidence of excess ammonia in the glyphosate-sensitive 
but not the glyphosate-adapted cells. Both cell types readily absorbed glyphosate from the medium, 
with a rapid linear uptake observed during the first eight hours following exposure. This demonstrates 
that glyphosate would be present in food sources derived from glyphosate-exposed plants. 
The excess ammonia observed in glyphosate-treated plants could be due to increased activity of 
phenylalanine ammonia lyase (PAL), an enzyme found in plants, animals, and microbes, that catalyzes 
the reaction that converts phenylalanine to trans-cinnamate, releasing ammonia [22]. In studies on 
transgenic tobacco, it was demonstrated that a decrease in the aromatic amino acid pool sizes (a direct 
consequence of glyphosate exposure) results in an enhancement of metabolic flux through the 
shikimate pathway, which leads to a rise in PAL activity as well as a doubling of the levels of 
chlorogenic acid, a polyphenolic compound related to cinnamate [23]. It has been proposed that 
glyphosate achieves part if not all of its growth-retardation effects on plants through induction of PAL 
activity [24]. The growth disruption could be due either to toxicity of the derived phenolic compounds [25] 
or to direct toxicity of the ammonia. A study of olive trees showed that there is a direct relationship 
between the total phenol concentration and PAL activity, suggesting that PAL is a major producer of 
phenolic compounds [26]. Glyphosate has been shown to increase PAL activity in both soybean 
seedlings [27] and in corn [28]. 
Under stress-inducing environments, the secondary metabolites derived from certain protein 
synthesis pathways become disproportionately important, and enzyme regulation induces dramatic 
shifts in the production of the amino acids versus the secondary metabolites. A study comparing 
glyphosate exposure with aromatic protein deprivation in plants found several effects in common, but 
there was a striking anomaly for glyphosate in that it caused a 20-fold increase in the synthesis of the 
rate-limiting enzyme for a pathway leading to flavonoid synthesis, as a side branch of the tryptophan 
synthesis pathway [29]. More generally, there is substantial evidence that glyphosate induces the 
synthesis of monophenolic compounds as well as the polyphenolic flavonoids, in both plants [30] and 
microbes [31], with concurrent depletion of aromatic amino acid supplies. When carrots are exposed to 
high doses of glyphosate, they produce significant amounts of various phenolic compounds as well as 
shikimic acid [32]. The significance of this will become apparent later on in Section 4 on sulfate 
transport. Elevated amounts of shikimate-derived benzoic acids such as protocatechuate and gallate are 
also found in plants exposed to glyphosate [29]. Strains of nitrogen-fixing bacteria in the soil produce 
hydroxybenzoic acids in the presence of glyphosate [31]. This digression towards the competing 
pathways to produce phenolic and benzoic acid compounds may well explain the suppression of 
aromatic amino acid synthesis by glyphosate. 
Even Roundup Ready® crops typically experience slowed growth following glyphosate ap- 
plications, and this has been attributed to glyphosate’s role as a chelator of micronutrients. In early 
work, glyphosate was shown to interfere with the uptake of the divalent cations, calcium and 
magnesium, through soybean roots [33]. Glyphosate severely reduced calcium content in the mitochondria 
of both root and leaf cells. Since magnesium was also affected, but potassium was not, the authors 
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suggested that this property might hold for all divalent cations. More recent greenhouse experiments 
demonstrated that glyphosate application to the root system decreased the levels of calcium, 
magnesium, iron and manganese in the seeds of the plants [34]. It was proposed that glyphosate binds 
to and immobilizes all of these divalent micronutrients, impairing their uptake by the plant. These 
glyphosate-induced deficiencies would carry over to the food supply, leading to deficiencies in these 
nutrients in humans who consume foods derived from glyphosate-exposed crops. 
Evidence of disruption of gut bacteria by glyphosate is available for both cattle and poultry. It has 
recently been proposed that glyphosate may be a significant factor in the observed increased risk to 
Clostridium botulinum infection in cattle in Germany over the past ten to fifteen years [35]. 
Glyphosate's demonstrated toxicity to Enterococcus spp. leads to an imbalance in the gut favoring 
overgrowth of the toxic Clostridium species. Glyphosate has been shown to have remarkable adverse 
effects on the gut biota in poultry [36], by reducing the number of beneficial bacteria and increasing 
the number of pathogenic bacteria in the gut. Highly pathogenic strains of Salmonella and Clostridium 
were found to be highly resistant to glyphosate, whereas beneficial bacteria such as Enterococcus, 
Bacillus and Lactobacillus were found to be especially susceptible. Due to the antagonistic effect of 
the common beneficial bacterium Enterococcus spp. on Clostridia, toxicity of glyphosate to E. spp 
could lead to overgrowth of Clostridia and resulting pathologies. 
Pseudomonas spp. is an opportunistic pathogen and an antibiotic-resistant Gram-negative bacterium 
that has been shown to be able to break down glyphosate to produce usable phosphate and carbon for 
amino acid synthesis, but a toxic by-product of the reaction is formaldehyde [37], which is neurotoxic, 
and low levels of formaldehyde can induce amyloid-like misfolding of tau protein in neurons, forming 
protein aggregates similar to those observed in association with Alzheimer's disease [38]. 
A recent genome-wide study of the effect of glyphosate on E. coli revealed metabolic starvation, 
energy drain, and other effects involving genes that are poorly understood [39], in addition to 
suppression of the shikimate pathway. For example, half of the eight genes encoding ATP synthase 
were downregulated, suggesting an impairment in mitochondrial ATP synthesis. At the same time, 
genes involved in importing sugars were upregulated, which suggests a switch to anaerobic 
fermentation, producing pyruvate (a much less efficient solution) rather than oxidizing glucose for full 
breakdown to carbon dioxide and water. A switch to anaerobic metabolism is also suggested from a 
study showing that, in soil treated with glyphosate, the total count of fungi was significantly increased, 
while oxygen consumption was significantly inhibited [40]. 
Research conducted by exposing an outdoor aquatic mesocosm (approximating natural conditions) 
to two pesticides and two herbicides revealed a unique effect (among the four toxins studied) of the 
herbicide, glyphosate, to destroy tadpoles. Following only a two-week exposure period, two species of 
tadpoles were completely eliminated and a third one was nearly exterminated, resulting in a 70% 
decline in the species richness of tadpoles [41]. Other experiments on bullfrog tadpoles showed that 
prior glyphosate exposure reduced the survival rates of tadpoles exposed to the fungal pathogen, 
Batrachochytrium dendrobatidis (Bd). [42]. It is thus conceivable that glyphosate may be instrumental 
in the worldwide decimation of frogs currently taking place [43]. This also suggests that glyphosate 
disrupts embryonic development, a topic to which we will return later. 
An insidious issue with glyphosate is that its toxic effects on mammals take considerable time to be 
overtly manifested. Studies on Wistar rats exposed to the highest levels of glyphosate allowed in water 
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for human consumption for 30 or 90 days showed enhanced lipid peroxidation and glutathione peroxidase 
activity, indicators of oxidative stress [44]. A long-term study conducted on rats showed remarkable 
pathologies that became apparent only after the three-month period that is usually allotted for toxicity 
trials. In this experiment, rats were monitored over their entire lifespan, while being fed either 
genetically modified (GM) or non-GM maize that had been optionally treated with Roundup® [9]. The 
rats that were chronically exposed to Roundup® developed several pathologies over the course of their 
lifespan, including large mammary tumors in the females and gastrointestinal, liver and kidney 
pathologies, especially in the males. The males developed both skin and liver carcinomas. Premature 
death in the treated male rats was mostly due to severe hepatorenal insufficiencies. Other researchers 
have shown that oral exposure to glyphosate in drinking water can induce DNA damage to mouse cells 
drawn from blood and liver [45]. 
Researchers have discovered that Roundup® is sometimes much more toxic than glyphosate by 
itself, and this discrepancy can be explained by the fact that Roundup® includes a surfactant which 
greatly enhances cytotoxic effects of glyphosate [46]. Specifically, the surfactant, TN-20, commonly 
found in glyphosate-based herbicides, was studied for its effect on glyphosate toxicity to rat cells in 
vitro. The results showed that the combination of the surfactant and glyphosate led to mitochondrial 
damage, apoptosis, and necrosis, under conditions where neither substance working alone achieved 
this effect. It was proposed that TN-20 disrupts the integrity of the cellular barrier to glyphosate uptake. 
A study on three microorganisms commonly used as starters in dairy technologies demonstrated 
that Roundup®, but not glyphosate, inhibited microbial growth at lower concentrations than those 
recommended in agriculture [47]. This result illustrates an amplified effect of glyphosate's toxicity 
through the adjuvants found in Roundup®. The authors also suggested that a recent loss of 
microbiodiversity in raw milk may be explained through the same toxic mechanisms. 
In humans, a prolonged accidental skin exposure to a glyphosate-surfactant herbicide has been 
shown to produce local swelling, bullae, and exuding wounds, followed by osteopenia, neurological 
impairment, and reduced nerve conduction [48]. Similarly oral exposure to glyphosate produces 
chemical burns and ulceration of the oral cavity [49]. 
3. Gut Dysbiosis, Autism and Colitis 
It is now well established that autism spectrum disorder (ASD) is associated with dysbiosis in the 
gut [50], and, indeed, this is viewed by many as an important contributor to ASD [51]. An increase in 
short chain fatty acids and ammonia in the gut has been found in association with autism [52,53]. Since 
these are by-products of anaerobic fermentation, this suggests an overgrowth of anaerobic bacteria 
such as Clostridia, Bacteriodetes, and Desulfovibrio. Clostridia have indeed been found in excess in 
the feces of autistic children [54]. By-products of fermentation by anaerobes, such as phenols, amines, 
ammonia, and hydrogen sulfide, can be toxic to the large bowel [1,8].  A strong link between autism 
and hepatic encephalitis has been identified [55], where the key underlying pathology may be excess 
ammonia in the blood stream. Ammonia plays an important role in the etiology of hepatic encephalopathy 
associated with both acute and chronic liver dysfunction [56,57]. The source of the ammonia is 
believed to be intestinal bacteria, including those in both the small and large intestine [58]. Impaired 
liver function prevents detoxification of ammonia via the urea pathway. Thus, the increased activity of 
Entropy 2013, 15 1422 
 
 
PAL induced by glyphosate [27,28] could play a role in creating a hyperammonemic environment in 
the gut and initiating subsequent pathology. 
Indeed, there is now evidence that gut microbes can produce ammonia from phenylalanine via 
PAL [59]. A unique mouse phenotype has recently been identified that is defined by the behavior of its gut 
bacteria [60], and the authors suggest that this phenotype can be explained through increased 
metabolism of phenylalanine via the PAL pathway. Furthermore, this unique phenotype is also 
associated with excess synthesis of p-cresol, via a pathway involved in tyrosine breakdown. These 
authors go on to propose that the known sulfate deficiency associated with autism [61,62] may be 
explained by the depletion of sulfate through sulfation of p-cresol produced from tyrosine by 
Clostridium difficile in the gut [63,64], in order to detoxify it. As we will explain in the next section, 
we believe that, in fact, p-cresol and other phenolic compounds are part of the solution rather than the 
cause, with respect to impaired sulfate transport. 
C. difficile is a well-established causal factor in colitis [65]. The incidence of C. difficile-associated 
disease has increased significantly in North America in recent years, and research into the association 
of this increase with inflammatory bowel disease has borne fruit [66]. In an observational study 
involving patients in a hospital in Wisconsin between 2000 and 2005, it was shown that C. difficile 
infection was almost nonexistent in patients with inflammatory bowel disease prior to 2003, but the 
rate grew from 4% to 7% to 16% in 2003, 2004, and 2005. One hypothesis presented was antibiotic 
use disrupting the beneficial gut bacteria, but it is conceivable that increased exposure to glyphosate is 
contributing to this increase. 
A higher level of p-cresol in the urine has been associated with lower residual sulfonation [67] and with 
autism [68]. p-Cresol, formed via anaerobic metabolism of tyrosine by bacteria such as C. difficile [64], is a 
highly toxic carcinogen, which also causes adverse effects on the central nervous system, the 
cardiovascular system, lungs, kidney and liver [69]. A recent paper found that formula-fed infants had 
an overrepresentation of C. difficile in the gut bacteria [70]. In a case-control study, children with 
autism were found to be significantly more likely to have been formula-fed rather than breast-fed [71]. 
The study did not distinguish between organic and non-organic formula, but one can surmise that  
non-organic soy formula might be contaminated with glyphosate, and this could be a contributing 
factor to both the autism and the C. difficile. Urinary bacterial metabolites of phenylalanine, such as 
benzoic and phenylacetic acids, and of tyrosine (p-hydroxybenzoic acid and p-hydroxyphenylacetic acid) 
have been found to be elevated in association with several different diseases reflecting impaired 
intestinal resorption, including coeliac disease, cystic fibrosis, and unclassified diarrhoea [72]. It was 
proposed that these metabolites were produced by the gut bacteria. High concentrations of an abnormal 
phenylalanine metabolite have been found in the urine of people with autism and schizophrenia, up to 
300x normal adult values, which is likely due to multiple species of anaerobic bacteria in the 
Clostridium genus [73]. Others have detected abnormally high concentrations of hippurate in the urine 
in association with autism [74]. Hippurate is a liver metabolite of benzoic acid [75]. Thus a variety of 
different compounds representing a deflection of aromatic amino acid synthesis towards oxidized benzene 
derivatives have been found in association with various digestive disorders and neurological disorders. 
Studies have convincingly shown an inflammatory mucosal immunopathology in children with 
regressive autism characterized by infiltration of intestinal epithelial lymphocytes [76]. The infiltration 
of immune system cells like lymyphocytes and eosinophils is a direct response to the impaired barrier 
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function. As will be seen in the next section, we propose that this dysbiosis is caused principally by 
impaired sulfate supply to the mucosa, and that the toxic phenolic compounds both assist in correcting 
this deficiency and induce inflammatory responses due to their oxidizing effects. 
4. Sulfate Transport Impairment and Phenol Synthesis 
Autism is a disorder involving impaired social skills and neurodevelopmental delay that has reached 
epidemic proportions in recent years, with one in 50 children born in the United States today now 
classified on the autism spectrum, according to the U.S. Centers for Disease Control and Prevention. 
Impaired sulfur oxidation and low levels of serum sulfate have been established in association with 
autism since 1990, as evidenced by the following quote from [77]: “These results indicate that there 
may be a fault either in manufacture of sulphate or that sulphate is being used up dramatically on an 
unknown toxic substance these children may be producing” (p. 198). 
In this section, we develop a novel hypothesis for the effect of glyphosate on aromatic amino acids 
in plants and microbes. Our arguments depend upon the observation that glyphosate, a short  
carbon-nitrogen chain with a carbonyl group and a phosphate group, is a strong anionic kosmotrope, 
since both carbonate and phosphate have this property. Sulfate is also a kosmotrope, whereas nitrate is 
a chaotrope. Kosmotropes and chaotropes represent opposite extremes on the Hofmeister series [78,79], 
where kosmotropes tend to structure the water surrounding them and to desolubilize proteins, whereas 
chaotropes destructure the water and solubilize proteins. Studies on fatalities due to acute over-exposure to 
glyphosate reveal hemodynamic disturbances, including intravascular disseminated coagulation (DIC) 
and multiple organ failure, associated with high serum concentrations of glyphosate (over 800 mg/L) [80]. 
We suspect this has to do with glyphosate's effect as a potent kosmotrope, causing a "salting out" of 
blood proteins and resultant coagulation and a “no-flow” situation [81]. 
Molecules with a carbon ring and an available attachment site for sulfate (e.g., phenolic 
compounds) are attractive for the purpose of transporting sulfate through the bloodstream when the 
kosmotropic load is elevated. Phenolic compounds like p-cresol can be readily sulfated in the gut, and 
this provides an opportunity to transport sulfate through the hepatic portal vein in the presence of 
glyphosate. The ring supports a charge distribution that diffuses the negative charge and suppresses the 
water-structuring properties of sulfate, thus preventing the vascular disturbances. A single phenol can 
perform this feat multiple times, as the sulfate can be attached to the phenol in the colon via a phenol 
sulfotransferase, and the liver utilizes sulfatases and sulfotransferases to transfer the sulfate moiety 
from the phenol to an available substrate, typically a xenobiotic or a sterol [82]. Thus, phenols could 
be responsible for supplying the sulfate critically needed to detoxify xenobiotics and bile acids and to 
produce various sterol sulfates, as well as supplying sulfate to the pancreas to be incorporated into 
mucopolysaccharides being released into the gut along with proteases by acinar cells [83].  
In this scenario, the glyphosate itself, due to its kosmotropic properties, is disrupting the transport 
of free sulfate, and therefore the aromatic amino acids are oxidized into various phenolic compounds 
in order to compensate for this problem. Unfortunately, once they are unsulfated, the phenols become 
toxic, as they will react destructively with phospholipids and DNA through one-electron transfer [84].  
Although flavonoids are generally considered to be beneficial to health, the biological mechanisms 
behind their benefit are not yet established. In [85], it is stated that “the potential role of microbial 
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metabolism in the gastrointestinal tract is often overlooked”. These authors propose that monophenolic 
derivatives are likely produced through ring fission of flavonoids by the gut microflora in the colon. 
Thus, flavonoids can promote sulfate transport to the liver via this process. Furthermore, flavonoids 
themselves can be both glucuronylated and sulfated [85,86], especially at the 4'-OH position [87], so 
they could serve directly as sulfate transporters without being broken down. In fact, we hypothesize 
that their role in sulfate transport is the reason for their abundant synthesis in plants in the presence of 
glyphosate at the expense of tryptophan [29]. Since they are less toxic than monophenols, they become 
attractive for sulfate transport in the presence of glyphosate. 
Figure 1. Schematic of cyclical process that could be utilized to transport sulfate from the 
gut to the liver in the face of glyphosate contamination in the hepatic portal vein. Phenolic 
compounds derived from aromatic amino acids would be cycled back and forth between 
the gut and the liver, sulfated during transport from the gut to the liver and glucuronylated 
during transport back from the liver to the gut. Ultimately, a sulfate reducing bacterium 
could metabolize the phenol, consuming sulfate. 
 
The fact that glyphosate suppresses both alkaline and acid phosphatase activity in in vitro assays [88] 
as well as extracellular alkaline phosphatase synthesis in algae [89] suggests that phosphate faces the 
same problem as sulfate in plants, in the presence of glyphosate, and hence enzymatic activity that 
produces free phosphate is suppressed. It is interesting to note that autism is associated with elevated 
serum levels of pyridoxal phosphate (vitamin B6) even in the absence of supplements [90]. Despite 
this, supplemental B6 has been shown to alleviate symptoms of autism [91,92]. We hypothesize that 
vitamin B6 is exploited to transport phosphate safely in the presence of glyphosate. The pyridoxal ring 
distributes the negative charge on the phosphate anion in the same way that phenols distribute the 
charge on sulfate, thus allowing phosphate to be transported in a non-kosmotropic form. 
Glyphosate’s kosmotropic effects can be counteracted through buffering of chaotropes in the blood, 
and this could be a factor in the increased levels of both ammonia [93] and various oxides of nitrogen, 
including nitric oxide, nitrite, and nitrate [94–96] observed in association with autism.  
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Thus, autism is associated with dysbiosis in the gut [50,51], along with impaired sulfate metabolism and 
a significantly reduced level of free sulfate in the blood stream (only one-third of the normal level) 
[63,97–101], excess production of nitric oxide [94–96], overgrowth of phenol-producing bacteria like 
C. difficile [101], and increased urinary levels of the toxic phenol, p-cresol [68]. Autism is also 
associated with a decreased ability to sulfate and hence detoxify acetaminophen, which aligns with 
insufficient sulfate bioavailability. A genetic defect in the phenol sulfotransferase gene is associated 
with autism [77]: this enzyme becomes more essential in the context of glyphosate contamination. All 
of these observations can potentially be explained by the effects of glyphosate on the gut bacteria and 
on the blood stream. 
Both colitis and Crohn’s disease are associated with sulfate depletion in the gut [102], which could 
be caused by the impaired sulfate transport problem induced by glyphosate exposure. An overgrowth 
of the sulfur-reducing bacterium, Desulfovibrio, has been found in association with autism [103]. 
Sulfate-reducing bacteria can utilize aliphatic and aromatic hydrocarbons as electron donors, and 
therefore they can play an important role in detoxifying toxic phenolic compounds [104–108]. Thus, 
the presence of Desulfovibrio in the gut may serve a dual purpose by metabolizing phenolic compounds 
while also disposing of free sulfate, which could be problematic if allowed to enter the blood stream in 
the presence of glyphosate. Thus, we hypothesize that, in the context of glyphosate in the vasculature, 
aromatic amino acids are diverted into phenolic compounds which can safely transport sulfate from the 
gut to the liver. The liver can then transfer the sulfate to another metabolite, such as a steroid, and then 
ship the phenol back to the digestive system for another round via the bile acids following 
glucuronidation [108]. Possibly after multiple rounds, the phenol is finally metabolized by a sulfate-reducing 
bacterium in the colon. This idea is schematized in Figure 1.  
5. Evidence that Glyphosate Inhibits CYP Enzymes 
The evidence that glyphosate inhibits CYP enzymes comes from several directions. There are 
studies showing inhibition of aromatase, a CYP enzyme that converts testosterone to estrogen, and 
studies showing enhancement of retinoic acid, which could be achieved by suppressing the CYP 
enzyme involved in its catabolism. Finally, there are studies that directly show inhibition of 
detoxifying CYP enzymes in both plants and animals. 
Two studies point to a disruption of aromatase activity [109,110]. In [109], as little as 10 ppm. of 
glyphosate disrupted aromatase activity in human liver HepG2 cells, a well-established cell line to 
study xenobiotic toxicity. In [110], it was shown that aromatase activity is disrupted in human 
placental cells at a concentration 100 times lower than that recommended in agricultural use. 
Furthermore, even small amounts of the adjuvants present in Roundup® could substantially enhance 
this effect of glyphosate, probably by enhancing the ease with which it gains access to the membrane-bound 
protein. In experiments with oyster larvae, Roundup® was found to be toxic at less than 1/20 the 
concentration of glyphosate needed to induce toxicity, thus exhibiting the enormous enhancing effect 
of Roundup®'s adjuvants [111]. 
Retinoic acid plays a key role in embryonic development, where its tightly-regulated concentration 
levels impact developmental stages [112]. Due to reports of neural defects and craniofacial 
malformations in children born in regions where glyphosate-based herbicides are used, a group of 
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researchers investigated the effects of low doses of glyphosate (1/5,000 dilutions of a commercial 
glyphosate-based herbicide) in development of African clawed frog embryos and chick embryos [113]. 
The treated embryos were highly abnormal: the frog embryos developed into tadpoles with cranial 
deformities, and microcephaly was observed in the chick embryos. They traced this effect to an 
increase in endogenous retinoic acid (RA) activity, and showed that cotreatment with an RA antagonist 
prevented the deformities. 
This increase in RA activity can be explained via inhibition of a CYP enzyme. A novel 
member of the CYP family has been discovered which is induced by retinoic acid and involved 
in its catabolism [114,115]. It is present in mammalian embryos and in the brain. Thus, if this 
enzyme is suppressed by glyphosate, it would explain the observed effect that glyphosate enhances 
levels of retinoic acid in embryonic development. 
A study conducted in 1998 demonstrated that glyphosate inhibits cytochrome P450 enzymes in 
plants [116]. CYP71s are a class of CYP enzymes which play a role in detoxification of benzene 
compounds. An inhibitory effect on CYP71B1l extracted from the plant, Thlaspi arvensae, was 
demonstrated through an experiment involving a reconstituted system containing E. coli bacterial 
membranes expressing a fusion protein of CYP71B fused with a cytochrome P450 reductase. The 
fusion protein was assayed for activity level in hydrolyzing a benzo(a)pyrene, in the presence of 
various concentrations of glyphosate. At 15 microM concentration of glyphosate, enzyme activity was 
reduced by a factor of four, and by 35 microM concentration enzyme activity was completely 
eliminated. The mechanism of inhibition involved binding of the nitrogen group in glyphosate to the 
haem pocket in the enzyme. 
A more compelling study demonstrating an effect in mammals as well as in plants involved giving 
rats glyphosate intragastrically for two weeks [117]. A decrease in the hepatic level of cytochrome 
P450 activity was observed. As we will see later, CYP enzymes play many important roles in the liver. 
It is plausible that glyphosate could serve as a source for carcinogenic nitrosamine exposure in 
humans, leading to hepatic carcinoma. N-nitrosylation of glyphosate occurs in soils treated with 
sodium nitrite [118], and plant uptake of the nitrosylated product has been demonstrated [119]. 
Preneoplastic and neoplastic lesions in the liver of female Wistar rats exposed to carcinogenic 
nitrosamines showed reduced levels of several CYP enzymes involved with detoxification of 
xenobiotics, including NADPH-cytochrome P450 reductase and various glutathione transferases [120]. 
Hence this becomes a plausible mechanism by which glyphosate might reduce the bioavailability of 
CYP enzymes in the liver. 
Glyphosate is an organophosphate. Inhibition of CYP enzyme activity in human hepatic cells is a 
well-established property of organophosphates commonly used as pesticides [121]. In [122], it was 
demonstrated that organophosphates upregulate the nuclear receptor, constitutive androstane receptor 
(CAR), a key regulator of CYP activity. This resulted in increased synthesis of CYP2 mRNA, which 
they proposed may be a compensation for inhibition of CYP enzyme activity by the toxin. CYP2 plays 
an important role in detoxifying xenobiotics [123]. 
Beginning in around 2006, an alarming die-off of honeybees became apparent in the United States, 
and researchers are still struggling to understand what is causing this die-off [124]. Since the 
application of glyphosate also reached record levels that year, and has continued to increase since then, 
with no abatement in the bee colony collapse disorder, glyphosate could be playing a role in the bees' 
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plight. While correlation does not necessary imply causation, there are strong reasons why glyphosate 
might interfere with bees' resistance to other environmental toxins. At first glance, pesticides might be 
more highly suspect, since bees are, after all, an insect. However, honeybees have an innate resistance 
to most pesticides, which unfortunately depends upon several CYP enzymes. For example, metabolic 
detoxification mediated by CYPs contributes significantly to honey bee tolerance of pyrethroid 
insecticides [125]. Thus, the fact that glyphosate disrupts CYP enzymes would suggest that exposure 
to glyphosate would leave bees especially vulnerable to pesticides in their environment, resulting in a 
synergistic effect. A 2005 study in Alberta (Canada) revealed a reduced wild bee abundance and  
highly-correlated reduced pollination in GM canola compared with organically grown canola [126], 
with Roundup-treated non-GM canola coming in at an intermediate level. A study comparing bees 
exposed to glyphosate and/or Roundup® against a control population demonstrated a significantly higher 
mortality rate in the glyphosate-exposed bees (p < 0.001) [127].  Neonicotinoids such as imidacloprid 
and clothianidin can kill bees, and have been implicated in colony collapse disorder [128]. However, 
this toxic effect is likely synergistic in combination with glyphosate, as would occur with bees 
ingesting herbicide-contaminated pollen. Glyphosate is an organophosphate, and a study of human 
self-poisoning has demonstrated that organophosphate ingestion synergistically greatly enhances the 
toxicity of ingested neonicotinoids [129]. 
6. The Path to Obesity 
Having established a plausible mechanism whereby glyphosate’s effects on gut bacteria would lead 
to depleted sulfate supplies in the gut with resulting inflammatory bowel disease, we now turn our 
attention towards the likely consequences of the resulting “leaky gut syndrome.” It has been proposed 
that the exponential increase in the production of synthetic organic and inorganic chemicals may be 
causal in the current world-wide obesity epidemic, due to alterations in body chemistry that promote 
weight gain [130]. These chemicals are better known for causing weight loss at high exposure levels, 
and this apparent paradox can be explained with respect to glyphosate, by invoking its known effect of 
depleting tryptophan in plants and microbes. Its effect on CYP enzymes in the liver will compound the 
problem, due to the impaired ability to detoxify synthetic chemicals, which are increasingly present in 
the environment. In this section we will explain how glyphosate’s depletion of tryptophan bioavailability 
can lead to obesity, and in Section 6 we will provide evidence that extreme depletion of tryptophan in 
the absence of obesity can cause severe impairment of the intestinal barriers, resulting in weight loss 
and anorexia, due to an inability to transport critical micronutrients across the damaged gut barrier. 
Tryptophan is an essential amino acid, meaning that mammalian cells cannot synthesize it. Serum 
tryptophan depletion leads to serotonin and melatonin depletion in the brain [131]. Since serotonin 
(derived from tryptophan) is a potent appetite suppressant [132], it follows that serotonin deficiency 
would lead to overeating and obesity. As we have seen, tryptophan supplies could be depleted both in 
plant-based food sources and through impaired tryptophan synthesis by gut bacteria as direct effects of 
glyphosate. The observed 20-fold increase in the synthesis of tryptophan-derived polyphenolic flavonoids 
in the context of glyphosate provides strong evidence of impaired tryptophan synthesis [29]. 
Tryptophan has several important roles in the body. Ordinarily, dietary tryptophan (aside from its 
role as an essential amino acid in protein synthesis) is taken up by the liver and either fully 
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metabolized to produce ATP or processed through the enzymatic action of tryptophan dioxygenase 
(TDO) and indole amine dioxygenase (IDO), via a pathway involving kynurenine and quinolinate as 
intermediaries to produce NAD+, an essential cofactor in ATP synthesis and DNA repair [133] (see 
Figure 2). Any tryptophan not taken up by the liver circulates in the blood, and is transported across 
the blood brain barrier (BBB). It becomes the (sole) precursor to the synthesis of the neurotransmitter 
serotonin and the hormone melatonin [131]. A low ratio of tryptophan to competing proteins in the 
blood stream leads to reduced transport of tryptophan across the BBB and subsequent impaired 
serotonin and melatonin synthesis in the brain. Thus, low serum tryptophan levels translates into a 
tendency towards weight gain due to suppressed serotonin signaling [132]. 
Figure 2. Illustration of tryptophan pathways in the body and the adverse effect of 
glyphosate on tryptophan bioavailability. IDO: indole amine dioxygenase; TDO: 
Tryptophan dioxygenase; G: glyphosate. 
 
However, under inflammatory conditions, and in response to pathogenic stimuli such as the 
lipopolysaccharide (LPS) in bacterial cell walls, tryptophan is converted into kynurenine by lymphoid 
tissues at the site of inflammation [134] and stockpiled by in situ macrophages and neutrophils [135–137] 
as kynurenine. Therefore, it is expected that inflammation in the gut would lead directly to serum 
tryptophan depletion, thus further reducing the bioavailability of tryptophan to the liver. There are 
several reasons why macrophages need to sequester kynurenine, the most important of which is likely 
to be the assurance of a localized resource to regenerate NAD+ following its depletion through the 
synthesis of poly-ADP ribose by poly(ADP-ribose)polymerase (PARP) [138–140]. Poly-ADP ribose 
plays an important role in the DNA repair mechanisms that are required following DNA damage, 
induced by the reactive oxygen and nitrogen species (ROS and RNS) released by macrophages to fight 
infection – superoxide, nitric oxide, and their reaction product, peroxynitrite. Superoxide is induced 
from oxygen in the artery wall by transfer of an electron from cytosolic NADPH to oxygen, and its 
synthesis is essential for killing invasive pathogens, but collateral exposure also leads to tissue damage. 
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Both the inflammatory cytokine interferon-γ (IFN-γ) and superoxide itself induce IDO synthesis, 
and IDO detoxifies superoxide by using it to break the pyrrole ring in tryptophan [141]. The DNA in 
the cell nucleus is highly vulnerable to superoxide exposure, which can lead to strand breaks. The 
synthesis of kynurenine from tryptophan by IDO results in replenishing the supply of NAD+ and 
NADP+, which has been depleted due to the activities of PARP as part of the DNA repair process. 
Studies have confirmed that serum tryptophan levels are low in association with obesity [142,143]. 
In [143], plasma tryptophan levels were monitored several times over the course of a twenty-four hour 
period, and it was confirmed that serum tryptophan levels were chronically depressed, and the levels of 
other competing large neutral amino acids were elevated, in obese subjects compared to controls. This 
pathology persisted even after weight reduction through intense dieting. 
A recent experiment involving transferring a strain of endotoxin-producing bacteria from the gut of 
an obese human to the sterile gut of germ-free mice demonstrated the dramatic obesogenic effect that 
over-production of endotoxin by gut bacteria can have [144]. These mice became obese over a 16-week 
trial period, when concurrently placed on a high-fat diet, and the obesity was associated with a low-grade 
chronic inflammatory state. Control germ-free mice on the same diet but without the infective agent 
did not become obese. It was hypothesized that chylomicrons produced for fat transport became a 
vehicle for endotoxin delivery to blood serum and subsequently to the liver and body fat stores, since 
inflammatory cytokines were found predominantly in the liver and epididymal fat pad rather than in 
the ilium. Since glyphosate induces a shift in gut bacteria towards endotoxin-producers, this effect can 
conceivably explain the association of a high-fat diet with obesity [145]. 
The obesity epidemic began in the United States in 1975, simultaneous with the introduction of 
glyphosate into the food chain, and it has steadily escalated in step with increased usage of glyphosate 
in agriculture (see Figure 1 in [146]). While it is common knowledge that Americans are continuing to 
grow more and more obese with each passing year [147,148], there may be less awareness that obesity 
aligns with glyphosate usage elsewhere in the world [149]. For example, South Africa arguably has the 
highest obesity rates in all of Africa [150], and it is also the African country that has most heavily 
embraced glyphosate usage since the 1970’s and has freely adopted genetically modified crops with 
little regulation [151,152]. According to World Health Organization statistics [153], only 2.7% of 
adults in the United Kingdom were obese in 1972, a number that rose to 25.8% in 1999. Today, two 
thirds of U.K. citizens are either overweight or obese. 
7. The Path to Inflammatory Bowel Disease and Anorexia Nervosa 
We have seen how obesity can develop following the depletion of tryptophan through its diversion 
into polyphenolic flavonoids as well as aggressive uptake into macrophages, to provide assurance of 
DNA repair mechanisms in the face of excess ROS and RNS. Subsequent impaired serotonin synthesis 
stimulates overeating behaviors. Here, we argue that severe tryptophan deficiency without sufficient 
fat stores to harbor toxins and supply sterol sulfates can result in an inability to control microbial 
invasion as a consequence of impaired release of antimicrobial peptides. This can lead, paradoxically, 
to anorexia nervosa, resulting in a highly inflamed digestive system, pathogenic penetration through 
leaky intestinal epithelium, uncontrollable diarrhea, and subsequent anorexia. 
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Obesity offers protection against gastrointestinal inflammation, in part because the endotoxin can be 
stored in adipose tissue, sparing the gut barrier from inflammatory damage. However, a more 
important factor may be the ability of adipose tissue to directly supply sulfated steroids. The 
sulfotransferase that sulfates serotonin, thus inactivating it, is found in many tissues, including brain, 
heart, liver, lung, kidney and spleen [154]. Insufficient sulfate supply would likely compromise this 
function, leading to poor serotonin regulation. There is an interesting connection between levels of 
serotonin and sterol sulfates in the blood serum. DHEA sulfate is the most prominent sterol sulfate in 
the serum besides cholesterol sulfate [155]. Patients with autism have anomalously low DHEA sulfate 
levels along with anomalously low serotonin [156]. Serum DHEA sulfate levels are inversely 
associated with visceral fat [157], and DHEA sulfate supplements can induce weight loss in morbidly 
obese postmenopausal women [158]. We hypothesize that DHEA sulfate levels are a hormonal signal 
of sulfate bioavailability, and low bioavailability leads to low serotonin which induces overeating, in 
order to produce visceral fat. Visceral fat is a source of estrone sulfate [159], which, we hypothesize, 
may compensate for some deficiencies in DHEA sulfate and alleviate the burden on the adrenal glands 
to produce sterol sulfates. This would also reduce the demand on phenols to transport sulfate and 
therefore alleviate the inflammatory gut disorder, restoring homeostasis. 
An important study elucidating the processes leading to inflammatory bowel disorder was 
conducted on male Ace2 knockout mice (Ace2−/y) [13]. Ace2 induces expression of the tryptophan 
transporter in the gut epithelium. Thus, these mice suffered from severe tryptophan deficiency. They 
responded to dextran sodium sulfate exposure with a much more severe colitis attack than their control 
littermates, leading to enhanced infiltration of inflammatory cells, increased intestinal bleeding, severe 
diarrhea, and weight loss. A series of further experiments revealed that a similar response could be 
provoked in the control mice by providing them with a diet that was specifically deficient in 
tryptophan. It was confirmed that the acute response was associated with impaired synthesis of 
antimicrobial peptides by macrophages, mediated by impaired mTOR (mammalian target of rapamycin) 
signaling. It is conceivable that the severe deficiency in tryptophan led to restricted protein synthesis in 
macrophages, preventing the synthesis of the antimicrobial peptide. Furthermore, the distribution of gut 
bacteria was profoundly affected by the Ace2−/y phenotype and by tryptophan deprivation. 
Thus, severe tryptophan deficiency, as might be induced by glyphosate’s interference with 
tryptophan synthesis in plants and microbes, can lead to an extreme inflammatory bowel disease that 
would severely impair the ability to absorb nutrients through the gut, due to inflammation, bleeding 
and diarrhea. This could easily explain the alarming increases that have been seen recently in 
inflammatory bowel diseases [16,17,160]. 
8. Cytochrome P450 Enzymes 
The cytochrome P450 (CYP) enzymes are a diverse, ancient class of enzymes that date back to 
three billion years ago, and play an important role in plant, animal, and microbial biology [161]. These 
enzymes participate in oxidation, peroxidation and reduction of compounds ranging from pharmaceutical 
drugs to environmental chemicals to endogenous bioactive molecules [123]. There are at least 18 
distinct CYP families in humans, which are classified as a series of numerical “CYP” classes. In 
humans, CYP1, CYP2, CYP3, and CYP4 P450 enzymes in the liver are essential for detoxification of 
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many xenobiotics [162]. Members of the CYP5 and CYP7 classes are essential for the formation of 
water-soluble bile acids from cholesterol in the liver. Bile acids act as powerful detergents to aid in the 
digestion of fats, and also provide a pathway for disposal of oxysterols. A loss-of-function mutation in 
CYP7B1 leads to liver failure in children, associated with high serum levels of oxysterols [163]. 
Both cholesterol and vitamin D3 synthesis and degradation depend upon various CYP enzymes. At 
least seven CYP enzymes have a role in converting acetate into sterols. Lanosterol 14α-desmethylase 
(CYP51A1) is pivotal in cholesterol synthesis. Two CYP enzymes in the liver catalyze 25- 
hydroxylation of vitamin D3 to its active form, and two other CYP enzymes catalyze the breakdown of 
vitamin D3 in the liver [164,165]. 
There is a growing epidemic of vitamin D deficiency in the United States. In a study on serum 25-
hydroxyvitamin D levels obtained from the National Health and Nutrition Examination Survey 
(NHANES) data, it was found that vitamin D3 levels fell sharply in the interval from 2001 to 2004 
compared to the interval from 1988 through 1994 [166]. While this problem is in part due to 
overaggressive sun avoidance practices, glyphosate’s interference with CYP proteins may play a role 
in disrupting vitamin D3 activation in the liver. 
Several CYP enzymes participate in steroid synthesis. Cytochrome P450 oxidoreductase deficiency 
(POR) is a newly described disorder of steroidogenesis [167]. Five crucial lipid hormones, aldosterone, 
androstenedione, cortisol, corticosterone and dehydroepiandrosterone (DHEA), are produced in the 
adrenal glands, testes and ovaries, and in the adrenal cortex. All steroid hormones are produced from 
cholesterol by these CYP enzymes, contained within the inner mitochondrial membrane. The lipophilic 
nature of these steroids allows them to diffuse across the lipid bilayers. CYP19A1 (aromatase), whose 
inhibition has been confirmed in association with glyphosate [109,110] converts androgenic precursors 
into estrogen. Suppressed aromatase synthesis has been found in the brain in association with autism [168], 
leading to the “super-male” profile associated with this condition [169]. 
CYP26A1 catabolizes retinoic acid; hence, its suppression would lead to excess retinoic acid 
bioavailability. CYP26A1 is induced by retinoic acid during neural differentiation, and its action leads 
to the degradation of retinoic acid, a necessary step towards maturation of the developing neurons [114]. 
The aryl hydrocarbon receptor (Ahr) gene induces CYP1B expression, leading to degradation of 
retinoic acid. Ahr-knockout mice accumulate excess retinoic acid in the liver [170]. Thus, if liver 
CYP1B expression were disrupted by glyphosate, it would lead to excess retinoic acid. Retinoic acid 
suppresses the synthesis of cholesterol sulfate, a crucial step in bile acid synthesis [171]; thus, excess 
retinoic acid in the liver should lead to impaired synthesis of bile acids and impaired fat metabolism. 
Mutations in CYP7A1 are associated with high serum LDL and high hepatic cholesterol content, 
along with deficient bile acid excretion [172]. Human CYP7B1 mutations lead to both defects in bile 
acid synthesis and spastic paraplegia, involving impaired myelin sheath in the spinal cord and 
uncontrolled movement disorders. The drug, clopidogrel (Plavix), administered to suppress life-
threatening stent thrombosis following cardiovascular surgery, depends upon a liver CYP enzyme, 
CYP2C19, to transform it into an activated metabolite. Patients with a loss-of-function mutation in this 
CYP enzyme have significant risk of an adverse event following surgery [173,174]. 
Glyphosate from food sources or as a contaminant in water would be likely to reach the liver in 
high concentrations through direct transport from the digestive system via the hepatic portal vein. It 
could be anticipated that glyphosate would disrupt many of the diverse CYP enzymes that are 
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bioactive in the liver, involved in cholesterol synthesis and metabolism, vitamin D3 synthesis and 
metabolism, the detoxification of xenobiotics, and regulation of retinoic acid. 
Glyphosate would also be expected to travel throughout the blood stream, disrupting any CYP 
enzymes it comes in contact with. Of particular concern are the two that regulate blood clotting 
(thromboxane A2 synthase: CYP5A1) and hemorrhaging (prostacyclin synthase: CYP8A1). CYP5A1 
stimulates platelet aggregation, whereas CYP8A1 inhibits platelet aggregation. The elderly often face 
instabilities in hemorrhaging and clotting leading to Disseminated Intravascular Coagulation (DIC) and 
life-threatening destabilization of the blood [175], which could be due to impaired function of these 
two enzymes. 
9. Glyphosate’s Potential Role in eNOS Dysfunction 
Thus far, we have developed a plausible argument for how glyphosate could disrupt gut microbiota, 
leading to inflammation, depletion of tryptophan, and subsequent obesity, or, in the extreme case, 
anorexia nervosa. We have also discussed the many roles of CYP enzymes, and proposed that 
glyphosate’s interference with CYP expression could lead to many pathologies that are commonly 
occurring today, such as vitamin D3 deficiency and abnormal blood clotting. 
Endothelial nitric oxide synthase (eNOS) is an orphan member of the CYP family. It is present in 
endothelial cells that synthesize nitric oxide (NO), where it induces vessel relaxation and therefore 
enhanced blood flow [176]. Both eNOS and CYP enzymes are heme-thiolate proteins with the same 
redox partner, a diflavoprotein reductase. However, eNOS, unlike the other CYP enzymes, requires 
tetrahydrobiopterin (BH4) as a cofactor for the synthesis of NO, and no other member of the CYP 
family is capable of synthesizing NO. 
It has recently been proposed that eNOS is a dual-purpose enzyme, producing NO when it is bound 
to calmodulin in the cytoplasm, and producing sulfate when it is bound to caveolin at the plasma 
membrane [177]. While no other CYP enzyme produces NO, this class is known to oxidize sulfur [178], 
an important aspect of their ability to detoxify sulfur-containing drugs. Red blood cells (RBCs) contain 
membrane-bound eNOS, and this has presented a puzzle to researchers, because the synthesis of NO 
by RBCs would be counterproductive, due to its high reactivity with hemoglobin to form a nitrosylated 
compound that is impaired in oxygen transport. Indeed, RBCs have mechanisms to maintain a very 
low concentration of the substrate L-arginine. However, it is highly plausible that RBCs use their 
eNOS to produce sulfate, which can then be combined with cholesterol to form cholesterol sulfate, 
known to be present in large amounts in RBC plasma membranes, where it has a stabilizing effect. 
A significant adverse effect of glyphosate is its hypothesized disruption of sulfate synthesis by 
eNOS in the endothelium. This effect contributes to the inflammation already present due to the escape 
of pathogenic bacteria through the impaired gut barrier. In fact, the two effects are synergistic, because 
the sulfate depletion incurred by eNOS dysfunction further compromises the gut barrier, where sulfate 
deficiencies due to transport problems are already present. Due to its homology with the CYP enzymes, 
eNOS is predicted to be susceptible to disruption by glyphosate, but only in its sulfate-synthesis function. 
The result will be endothelial damage due to superoxide exposure, along with sulfate deficiency. We 
hypothesize that such disruption is a significant heretofore overlooked component of glyphosate’s 
toxicity in mammals. 
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If, as proposed in [177], RBCs use eNOS to produce sulfate, then the sulfate can be combined with 
cholesterol to produce cholesterol sulfate, which, unlike cholesterol itself, is amphiphilic. RBCs are 
well positioned to deliver both cholesterol and sulfate to the tissues, supplying them with these 
essential nutrients. In [177], it was further proposed that endothelial cells produce sulfate catalyzed by 
eNOS, using superoxide as the oxidizing agent, a reaction that is catalyzed by sunlight exposure, and 
that the sulfate serves to replenish sulfate supplies to the glycocalyx, which is constructed from highly 
sulfated proteoglycans. Accumulation of sulfate deficiencies in the endothelial glycocalyx contributes 
significantly to vascular dysfunction [179]. Colitis is less prevalent in areas with a sunny climate [180], 
suggesting that sunlight improves intestinal health by increasing sulfate supply. 
Ingested glyphosate readily enters the vasculature, and hence membrane bound eNOS in RBCs and 
the endothelial wall is vulnerable to the disabling effects of glyphosate on the P450 active site. This, 
over time, would result in cholesterol and sulfate deficiencies, manifested as multiple disease states. It 
would also explain the pathology where eNOS synthesizes superoxide in an “uncoupled” mode [181], 
a pathology that has been proposed as a major source of inflammatory ROS and subsequent endothelial 
dysfunction. We hypothesize that the superoxide is prevented from oxidizing sulfur by the glyphosate, 
and thus becomes a destructive agent in the artery wall. 
9.1. Lysosomal Dysfunction 
In [177], it was proposed that lysosomal dysfunction could be predicted to follow long-term 
impairment of eNOS’ sulfate synthesis. Lysosomes, the “digestive system” of the cell, require 
substantial membrane cholesterol both to prevent hydrogen ion leaks and to protect membrane lipids 
from oxidative damage. Lysosomes also depend upon internalized sulfate, derived from heparan 
sulfate proteoglycans (HSPGs), to catalyze hydrolytic enzymes. Severe neurological dysfunction 
associated with lysosomal storage diseases involving impaired heparan sulfate homeostasis attest to the 
importance of sulfate in lysosomal function [182].  
It has become increasingly apparent that lysosomal dysfunction is a major factor in Alzheimer’s 
disease and Parkinson’s disease [183], as well as in cardiovascular disease [184] and heart failure [185]. 
Mitochondria are ordinarily constantly broken down and renewed by lysosomal processes, and, when 
these become impaired, large aged mitochondria become a source of reactive oxygen species that 
contribute significantly to neuronal damage. Cardiomyocytes, like neurons, are long-lived postmitotic 
cells that are especially susceptible to lysosomal disrepair [186]. 
9.2. Tetrahydrobiopterin 
The research literature has identified the cofactor tetrahydrobiopterin (BH4) as a significant player 
in eNOS function [187,188]. BH4 shifts the heme iron in eNOS to a high spin state, as well as 
increasing arginine binding, thus catalyzing the synthesis of NO by eNOS [187]. The synthesis of BH4 
from its substrate GTP is induced by IFN-γ, which, in turn, is induced by bacterial lipopolysaccharides 
(LPS) [189]. Thus, a bacterial infection will induce NO synthesis by eNOS. However, an excess of 
exogenous NO (as might be expected to occur through iNOS synthesis of NO during a bacterial 
infection) causes a decrease in NO synthesis by eNOS with a simultaneous increase in superoxide 
synthesis, an effect that can lead to severe hypertension in infants with congenital heart disease treated 
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with inhaled NO [187]. Superoxide’s reaction with NO to produce the highly toxic peroxynitrite 
(ONOO−), a potent bacteriocidal agent, is likely a critical factor. The subsequent oxidation of BH4 
disrupts its ability to act as a cofactor [188], and causes “eNOS uncoupling,” leading to superoxide 
synthesis in a highly disruptive feedback loop. 
We hypothesize that glyphosate’s nitrosylation of the active P450 site has derailed eNOS’ ability to 
synthesize sulfate in a contained environment at the caveolar sites in the membrane, thus requiring an 
alternative method to synthesize sulfate that exposes the cell to ROS. This method, as previously 
described in [177,190], involves the oxidation of homocysteine thiolactone, catalyzed by ascorbic acid 
(vitamin C) and retinoic acid (vitamin A). Since glyphosate enhances the bioavailability of retinoic 
acid through its suppression of the CYP enzyme that metabolizes it [115], this will help to promote the 
alternative reaction leading to sulfate synthesis in the artery wall from homocysteine thiolactone, but 
also requiring the inflammatory agent, superoxide, which over time destroys the artery wall, leading to 
endothelial dysfunction and cardiovascular disease. 
Elevated serum homocysteine is a strong risk factor in cardiovascular disease [191], in heart 
failure [192], in dementia [193], and in kidney failure [194,195]. We propose that sulfur-containing 
amino acids are deflected towards homocysteine synthesis in order to supply substrate for the 
critically-needed sulfate synthesis from superoxide in the artery wall. This also explains both the 
inflammation in the artery wall associated with atherosclerosis [196] and the deficiency in methionine 
associated with glyphosate, due to its depletion through its role as a substrate for homocysteine synthesis. 
10. Involvement of the Brain 
Impairment in the homeostasis of serotonin, an important neurotransmitter that regulates mood, 
appetite and sleep, has been linked to depression [197], autism [198], and Alzheimer’s disease [199,200], 
as well as obesity [132]. We have already seen how glyphosate’s induction of tryptophan-derived 
flavonoids and tryptophan’s incorporation into macrophages as kynurenine via IPO can explain 
reduced brain serotonin levels. Vitamin D3 deficiency can also contribute to mood disorders, and is 
hypothesized to be a key factor in the syndrome, Seasonal Affective Disorder (SAD), manifested as 
depressed mood specifically during the winter months [201]. Excess ammonia and zinc deficiency are 
also implicated in neuronal disorders, particularly Alzheimer’s disease, attention deficit hyperactivity 
disorder (ADHD), and autism. DNA methylation impairment is a factor in neuronal diseases, and 
glyphosate’s depletion of methionine could contribute to this defect. Below, we elaborate on the 
effects of serotonin depletion, excess ammonia, zinc depletion, and methylation impairments on 
disorders of the brain. We conclude this section with specific mention of a possible role for glyphosate 
in two other diseases of the brain: multiple sclerosis and Parkinson’s disease. 
10.1. Serotonin, Mood Disorders, and Autism 
Defects in serotonin transport are associated with a wide range of mood disorders. Major depression 
is accompanied by immune system activation, and the term “inflammatory and neurodegenerative (I&ND) 
hypothesis” has been used to describe this complex [202]. A demonstrated increased production of cytokines 
and immunoglobulins against bacterial-derived lipopolysaccharides points to increased gut permeability as 
a feature in depression [203]. Patients with depression and sleep disorders exhibit significantly lower 
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serum levels of tryptophan along with serum markers of inflammation such as IL-6 and IL-8 [204]. 
Selective serotonin reuptake inhibitors (SSRI’s) are a popular class of drugs to treat depression: they 
work by impairing serotonin reuptake in the synapse, effectively increasing its bioavailability for 
neuronal signaling. This strongly suggests that insufficient serotonin in the synapse could be a factor in 
depression. In fact, dietary tryptophan depletion leads to relapse in recovering depressed patients [197]. 
Defects in the serotonin transporter gene, 5-HTT, have been associated with antisocial personality 
disorder and violent behavior [205]. There has been a marked increase in the rate of irrational school-
associated violent deaths in the United States since 1990 [206], and glyphosate may play a role in this 
pattern through depletion of serotonin bioavailability. Disturbances in serotonin function in the brain 
are known factors in impulsive aggression, violence, and criminal behavior [207]. Farmers in India 
experienced anomalously high suicide rates following adoption of Western agricultural methods based 
on extensive use of Roundup® [208]. While an explanation based on economic stress has been 
proposed, suicide victims in general have low serotonin levels in the brain [209], so it is conceivable 
that serotonin suppression via depletion of tryptophan by glyphosate played a role in the suicides 
among farmers in India. 
Genetic mutations in serotonin transporter genes have been found in association with both obsessive 
compulsive disorder and autism [210]. A study comparing 40 children with idiopathic infantile autism 
with normal controls showed a significantly lower serum ratio of tryptophan to large neutral amino 
acids [211]. 35% of the children with autism had a ratio that was at least two standard deviations below 
the mean value from the control group. It has been shown that dietary tryptophan depletion exacerbates 
anxiety and repetitive ritualistic behaviors in autistic subjects [198], an effect that was surmised to be 
due to impaired serotonin synthesis. Researchers have studied a mouse model of a defective serotonin 
transporter gene which results in a decrease in the bioavailability of serotonin for neuronal signaling in 
the brain, and have shown that the genetically modified mice exhibit autism-like behaviors [212]. This 
strongly suggests that impaired serotonin supply in the brain is a feature of autism. 
Melatonin, produced from serotonin, is secreted by the pineal gland, primarily at night, and is a 
potent antioxidant and regulator of redox reactions [213,214]. Its neuroprotective role in aging and 
many neurodegenerative conditions such as Alzheimer’s disease and Parkinson’s disease is most likely 
due to its antioxidant effects [215–218]. Thus, it is anticipated that glyphosate would lead to impaired 
antioxidant protection, due to the suppression of melatonin synthesis, following the depletion of 
tryptophan as substrate, as previously discussed. Since melatonin is also a regulator of the wake/sleep 
cycle, impaired melatonin supply will lead to sleep disorders. 
10.2. Ammonia, Autism and Alzheimer’s Disease. 
As stated previously, glyphosate enhances ammonia synthesis in susceptible plants via activation of the 
enzyme PAL [22], and gut microbes could produce excess ammonia through enhanced PAL synthesis 
under the influence of glyphosate. A parallel between autism and hepatic encephalitis has been made, 
emphasizing the role that ammonia plays as a toxin in the brain in both cases [219,220]. Ammonia has 
also been proposed to play a critical role in the etiology of Alzheimer’s disease [221]. Thus, excess 
ammonia synthesis by gut bacteria under the influence of glyphosate could be a factor in both autism 
and Alzheimer’s disease. 
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10.3. A Role for Zinc Deficiency. 
Zinc deficiency is a major problem worldwide, particularly in the developing world, where limited 
access to zinc-rich foods such as shellfish and excess dietary exposure to phytates both contribute to 
the problem [222]. Phytates, found in many nuts and grains, bind to dietary minerals and interfere with 
their absorption. Lactobacilli and other beneficial gut bacteria produce the enzyme phytase, which 
catalyses the release of phosphate from phytates and improves the intestinal absorption of important 
minerals such as iron and zinc [223]. Because glyphosate reduces the number of these types of bacteria 
in the gut, it should enhance the chelating potential of phytates. This is likely a protective measure to 
avoid excess bioavailability of free phosphate, which is problematic in transport in the presence of 
glyphosate. Glyphosate’s known ability to itself chelate divalent cations is likely a factor as well. Zinc 
deficiency increases the risk of diarrhea, pneumonia and malaria in infants and young children. 
Zinc is the most abundant trace metal in the brain [224]. Most of the amyloid-β degrading enzymes 
are zinc metalloproteases, and zinc is also critical in the nonamyloidogenic processing of the amyloid 
precursor protein. Hence, zinc deficiency in the brain would be expected to lead to the build-up of 
amyloid-β, a key factor in the development of Alzheimer’s disease. Zinc deficiency has also been 
implicated in autism [225] and ADHD [226,227]. Zinc is released into the synapse along with the 
neurotransmitter glutamate, and it is required for memory function and the maintenance of synaptic 
health as we age [228]. In [225], anomalously low zinc levels in hair analyses were found in children 
on the autism spectrum. In [226], zinc sulfate supplements improved ADHD symptoms, an effect that 
could be attributed to the supply of sulfate as well as zinc. 
In [229], it was proposed that zinc deficiency along with excess exposure to copper may be a key 
factor in Alzheimer’s disease. A study conducted in South Africa revealed that zinc supplementation 
was not effective in raising plasma levels of zinc in zinc-deficient Alzheimer’s patients unless both 
vitamin A and vitamin D were simultaneously supplemented [230]. Hence, vitamin D3 deficiency 
(which could be caused by glyphosate’s impairment of liver CYP enzymes) may interfere with zinc 
absorption, further depleting the supplies to the tissues. 
10.4. Methylation Impairment 
Methylation impairment has been observed in association with autism [231] and Alzheimer’s  
disease [232], and this is caused by an inadequate supply of the substrate, methionine. While human 
cells are unable to synthesize methionine, it can be synthesized by many enteric bacteria, for example 
from cysteine via the transsulfuration pathway or through de novo synthesis from inorganic sulfur [233]. 
Glyphosate has been shown to significantly impair methionine synthesis in plants [21], and it may 
therefore be anticipated that it would have a similar effect in gut bacteria, which could then impair 
methionine bioavailability in humans. A further factor is the depletion of methionine through its 
deflection towards the transsulfuration pathway, as a precursor for homocysteine, which will be 
consumed to supply sulfate to the endothelial wall when eNOS’ sulfate synthesis is impaired. Since 
methionine is the source of methyl groups in methylation pathways, this effect of glyphosate could 
contribute directly to methylation impairment. 
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10.5. Molecular Mimicry and Multiple Sclerosis  
An increased incidence of inflammatory bowel disease has been found in association with multiple 
sclerosis (MS) [234]. This could be explained by the hypothesis that gut bacteria leaking into the 
vasculature cause an immune reaction, and that molecular mimicry leads to an autoimmune disorder 
resulting in destruction of the myelin sheath. A systematic search comparing reported sequences from 
all known human bacterial and viral agents against three known encephalitogenic peptides identified 
matching mimics predominantly in gut bacteria [235]. This could explain why no infective agents have 
been found in association with MS, but would also suggest that the recent increase in the incidence of 
MS [236] may be traced to inflammatory bowel disease, and, hence, to glyphosate. 
10.6. Dopamine and Parkinson’s Disease 
Since dopamine is synthesized from tyrosine and its precursor phenylalanine, tyrosine and 
phenylalanine depletion by glyphosate in both plants and microbes would be expected to reduce their 
bioavailability in the diet. It has been demonstrated that dietary reductions of phenylalanine and 
tyrosine induce reduced dopamine concentrations in the brain [237]. Impaired dopaminergic signaling 
in the substantia nigra is a key feature of Parkinson’s disease, and Parkinson’s risk has been associated 
with exposure to various pesticides, including the herbicide paraquat [238], although, to our 
knowledge, glyphosate has not yet been studied in this respect. However, exposure of C. elegans to 
glyphosate led to pathology in the nervous system in the region analogous to the nigrostriatal 
dopamine system associated with Parkinson’s disease [239]. 
Sulfate deficiency in the brain has been associated with Parkinson’s disease, as well as Alzheimer’s 
disease and Amyotrophic Lateral Sclerosis (ALS) [240]. We have argued above that glyphosate 
disrupts sulfate transport from the gut to the liver, and may interfere with sulfate synthesis by eNOS in 
the arterial wall and in RBCs and platelets, leading over time to severe sulfate deficiency throughout 
all the tissues. This would further impact these devastating diseases of the elderly, all of which are 
currently on the rise. 
11. Other Adverse Health Effects 
In this section, we will briefly mention several other pathologies in which we suspect that 
glyphosate may play a role in the observed increases in incidences in recent times. These include liver 
disease, cancer, cachexia, and developmental and fertility problems. 
11.1. Liver Disease 
Cytokines like TNF-α have been identified as a key factor in fatty liver disease, which has emerged 
as a growing public health problem worldwide [241]. In the extreme case, liver pathology develops 
into nonalcoholic steatohepatitis (NASH), which can lead to cirrhosis and liver failure. Cytokines 
induce inflammation which damages the liver. TNF-α inhibits insulin signaling [242,243], and 
cytokines can induce hepatic lipid overloading as well as liver fibrosis. Glyphosate’s role in inducing 
cytokines has already been developed in this paper. Obesity is associated with an increased expression 
of membrane-associated TNF-α in adipose tissue [244]. 
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11.2. Development and Fertility 
Cholesterol sulfate plays an essential role in fertilization [245] and zinc is essential to the male 
reproductive system [246], with a high concentration found in semen. Thus, the likely reduction in the 
bioavailability of these two nutrients due to effects of glyphosate could be contributory to infertility 
problems. Furthermore, glyphosate’s suppression of CYP protein activity would be expected to disrupt 
steroidogenesis. Inflammation leads to excess ROS and RNS exposure, which can damage DNA 
during cell replication, thus disrupting embryonic development. Glyphosate is capable of crossing the 
placental barrier [247]. Preeclampsia, a life-threatening condition for both the mother and the fetus that 
develops during the third trimester, is on the rise in America, and it has been proposed that this may be 
due to impaired sulfate supply [248], directly attributable to glyphosate exposure. For all of these 
reasons, glyphosate exposure would lead to infertility problems. 
According to the World Bank, the fertility rate in Argentina peaked at 3.39 in 1978, and has been 
declining steadily since then. The rate of decline accelerated during the last five years of the twentieth 
century. Social pressures certainly explain some of the drop in birth rate, but it is possible that 
environmental factors, such as glyphosate, also play a role. 1994 was the year that the FDA authorized 
the sale of Roundup Ready® (RR) soybeans in the North American market [249], and Argentina 
followed suit two years later. “After they were authorized in 1996, RR soybeans spread through 
Argentina at an absolutely unprecedented speed in the history of agriculture: an average of more than 
two million acres a year.” [249]. Argentina now exports 90% of its soybeans, which have become a 
monoculture crop and a cash cow. 
The fertility rate in Brazil has also dropped dramatically over the past several decades from six 
children per woman on average to fewer than two, now lower than that of the United States. Brazil is 
the second largest producer and exporter of soybeans in the world behind Argentina, and it has 
embraced genetically modified soybeans engineered to be glyphosate-tolerant as a means to increase 
production since the mid 1990’s. A rapidly evolving glyphosate-resistant weed population in Brazil 
due to genetically engineered glyphosate-tolerant crops is leading to increased use of glyphosate in 
recent years [250], the same time period in which a rapid drop in birth rates was observed. A steady 
increase in the rate of preterm births in Brazil over the past two decades has been noted, although the 
cause remains elusive. For instance, the rate increased from 6% in 1982 to 15% in 2004 in the town of 
Pelotas [251]. It is conceivable that increased exposure to glyphosate is contributing to this problem. 
This idea is in line with a study of an Ontario farm population, which revealed that glyphosate 
exposure any time during pregnancy was associated with a statistically significant increased risk of a 
late-pregnancy spontaneous abortion [252]. 
The birth rates in Western Europe have been declining for decades, with Germany’s rate now being 
1.36 children per woman. Birth rates have also been declining in the U.S since 2007, and are now at 
1.9 children per woman, according to the 2011 government statistics [253]. 
Testicular Leydig cells produce testosterone, and thus play a crucial role in male reproductive 
function. The protein StAR (steroidogenic acute regulatory protein) mediates the rate-limiting step in 
steroidogenesis. In a recent in vitro study of a mouse tumor Leydig cell line, Roundup was shown to 
disrupt StAR expression, thus interfering with testosterone synthesis [254]. It was shown that 
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Roundup® interferes with testosterone synthesis even at very low environmental doses, and higher 
doses were associated with necrosis and apoptosis in rat testicular cells. 
In [255], the in vitro effects of several different pesticides and herbicides on the synthesis of 
progesterone in testicular Leydig cells were investigated. Comparing eight different pesticides 
(Ammo®, Banvel®, Cotoran®, Cyclone®, Dual®, Fusilade® and Roundup®), it was found that, among 
these eight, Roundup® uniquely disrupted the cells’ ability to produce progesterone, reducing synthesis 
levels by up to 94% in a dose-dependent manner, without reducing total protein synthesis. 
For steroidogenesis, in addition to StAR, the side chain cleavage enzyme (P450scc) is required as 
well. The authors in [255] found that Roundup® inhibited both P450scc activity and StAR activity. 
Through formal measurements, it was determined that Roundup® reduced StAR protein levels by 90%, 
and inhibited P450scc activity by 71%. Glyphosate acting alone did not decrease steroidogenesis, 
suggesting that one or more of the adjuvants in Roundup® work in concert with glyphosate to suppress 
synthesis levels, e.g., by enabling glyphosate entry into the cell through a surfactant effect or perhaps 
acting on their own to inhibit synthesis. StAR plays an important role in steroid production not only in 
the reproductive organs but also in the adrenal glands. Thus, Roundup® exposure would be expected to 
adversely affect fertility and impair the synthesis of glucocorticoids and mineralocorticoids in the 
adrenal glands. 
Sea urchins are a popular model for studying mitosis in development. During mitosis, DNA damage 
or replication errors (for example due to excess exposure to ROS and RNS) leads to cell cycle arrest at 
certain “checkpoints” in G1, S, or G2 phase [256]. Cyclin-dependent protein kinases (CDKs) are 
important regulators of these checkpoints, signaling the “go-ahead” to transition to the next phase. 
Glyphosate in combination with the adjuvants in Roundup® experimentally induced a cell cycle delay 
in the transition from G2 to M phase in sea urchin embryos [257,258]. CDK1, acting on cyclin B, 
universally regulates the M-phase of the cell cycle, and Roundup® was shown to delay activation of 
CDK1/cyclin B via tyrosine 15 dephosphorylation in vivo, the likely means by which it interferes with 
cell cycle progression. 
11.3. Cancer 
While glyphosate is not generally believed to be a carcinogen, a study on a population of 
professional pesticide applicators who were occupationally exposed to glyphosate revealed a 
substantial increased risk to multiple myeloma [259]. Myeloma has been associated with agents that 
cause DNA damage [260], and DNA damage is a known consequence of chronic exposure to 
inflammatory agents, which, we have argued, are induced by glyphosate acting on the gut bacteria and 
suppressing CYP activity. Depleted supply of tryptophan as a substrate for poly-ADP ribose also 
contributes to DNA damage. 
Multiple myeloma accounts for around 15% of all lymphatohematopoietic cancers and around 2% 
of all cancer deaths each year in the United States [261]. Symptoms include bone destruction, 
hypercalcemia, anemia, kidney damage and increased susceptibility to infection. Obesity is a known 
risk factor [261], so one way in which glyphosate could increase risk indirectly is through its potential 
role as an obesogen. 
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Virtually all multiple myelomas involve dysregulation of a cyclin D gene [262]. Overexpression of 
cyclin D protein releases a cell from its normal cell-cycle control and could cause a transformation to a 
malignant phenotype. The fact that glyphosate suppresses cyclin-dependent kinase could be a factor in 
inducing pathological overexpression of the substrate, cyclin D. 
Another type of cancer that may be implicated with glyphosate exposure is breast cancer. The 
strongest evidence for such a link comes from the studies on rats exposed to glyphosate in their food 
supply throughout their lifespan, described previously, where some of the female rats succumbed to 
massive mammary tumors [9]. The incidence of breast cancer has skyrocketed recently in the United 
States, to the point where now one in three women is expected to develop breast cancer in their lifetime. 
Breast cancer risk is associated with certain polymorphisms of the CYP gene CYP1A2 and the 
sulfotransferase, SULT1A1 [263], and this in turn is associated with altered estrogen and testosterone 
expression, along with increased premenopausal breast density, a risk factor for breast cancer [264].  In [263], 
it was suggested that impaired sulfation capacity could lead to slower metabolism of sex hormones and 
subsequent increased breast density, as well as increased risk to breast cancer. This suggests that 
disruption of CYP1A2 and/or of sulfate bioavailability by glyphosate could lead to a similar result. A 
high body mass index (BMI) is associated with low CYP1A2 activity in premenopausal women  
(p = 0.03) [265], and, as we have seen, the low CYP1A2 activity may be a reflection of glyphosate 
suppression of CYP enzymes, in association with glyphosate depletion of tryptophan as an obesogenic 
influence, and glyphosate disruption of sulfate synthesis by eNOS. 
Obese postmenopausal women are at increased risk to breast cancer compared with lean 
postmenopausal women [266]. Studies on Zucker rats exposed to 7,12-dimethylbenz(a)anthracene, a 
chemical procarcinogen known to produce mammary adenocarcinoma in rats, demonstrated a much 
stronger susceptibility in obese rats compared to lean rats [267]. By the end of the study, obese rats had 
a 68% tumor incidence, compared to only 32% in lean rats. Subcutaneous fat expresses aromatase, and 
this increased expression has been suggested to play a role in inducing the increased risk, through the 
resulting increased estrogen synthesis [268,269]. It has been shown that inflammation increases aro- 
matase expression in the mammary gland and in adipose tissue. Since we have developed an argument that 
glyphosate can lead to inflammation, this again suggests a link between glyphosate and breast cancer. 
11.4. Cachexia 
Cachexia (muscle wasting) is a frequent debilitating complication of cancer, AIDS, and other 
chronic inflammatory diseases. The loss of muscle mass arises from accelerated protein degradation 
via the ubiquitin-proteasome pathway, which requires ubiquitin conjugating of designated proteins 
prior to their disposal [270]. The ubiquitin-conjugating pathway is stimulated by TNF-α, thus 
promoting muscle breakdown. In [271], it was shown that TNF-α upregulates expression of the 
ubiquitin ligase atrogin1/MAFbx in skeletal muscle, via the mitogen-activated kinase (MAPK) 
pathway. Thus increased TNF-α expression as a consequence of the inflammatory response associated 
with glyphosate exposure could be a factor in cachexia. 
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12. Glyphosate in Food Sources 
Following its successful commercial introduction in 1974 in the U.S., glyphosate has now become 
the dominant herbicide worldwide [6]. In large part this is due to its perceived lack of toxicity in 
humans. Since becoming generic in 2000, the dramatic drop in cost has encouraged global use of the 
generic version. Today, it is estimated that 90% of the transgenic crops grown worldwide are 
glyphosate resistant. The rapidly growing problem of glyphosate-resistant weeds is reflected in steady 
increases in the use of glyphosate on crops. 
Table 1. Estimated range for glyphosate usage in agriculture in the U.S. as a function of 
year. Range is estimated in units of millions of pounds. These data were obtained from the 
EPA [272]. 
Glyphosate usage for the USA (Range in millions of pounds)  
Year 2001 2003 2005 2007 
Range 85–90 128–133 155–160 180–185 
Today, Americans spray more than 100 million pounds of Roundup®, the most popular among 
Monsanto's chemicals, on their yards and farms every year. According to the most recent statistics 
from the U.S. Environmental Protection Agency (EPA) [272], the U.S. currently represents 25% of the 
total world market on herbicide usage. Glyphosate, first registered for use in 1974, has been the most 
common herbicide used in the United States since 2001, and the amount of glyphosate usage has 
increased steadily since then, as shown in Table 1. In 2007, the most recent year for which such 
numbers are available, the U.S. used an estimated 180 to 185 million pounds of glyphosate, more than 
doubling the amount used just six years before. 
The Western diet is a delivery system for toxic chemicals used in industrial agriculture. The diet 
consists primarily of processed foods based on corn, wheat, soy and sugar, consumed in high quantities. 
Chemical residues of insecticides, fungicides and herbicides like glyphosate contaminate the entire diet. 
Over the last decade, there has been widespread adoption in the U.S. of Roundup Ready® (RR) crops, 
particularly for the major productions of soy, beet sugar, and corn that supply the processed food 
industry. The recent alarming rise in type-2 diabetes has been attributed to excess intake of high 
fructose corn syrup, which has increased to unprecedented levels in the last decade [273]. This refined 
sugar is now usually derived from glyphosate-exposed GM corn. GM cotton is also increasingly being 
used as a source for cottonseed oil, widely present in processed foods such as potato chips, due to its 
low cost. A recent comparison between glyphosate-sensitive and glyphosate-resistant soybean crops 
revealed that the resistant plants took up much higher levels of glyphosate into their leaves [274]. A 
corollary is that these plants would be expected to yield much higher glyphosate concentrations in 
derived food sources, compared to their non-GMO counterparts. 
Confined animal feeding operations (CAFOs) are used to produce dietary animal protein for a 
mostly non-agrarian population [275]. Cows, pigs, sheep, goats, chickens and even farm-raised fish 
and shrimp are fed a diet primarily of genetically engineered grains and forage materials laced with 
herbicide. As a consequence, animal products like, eggs, butter, cheese and milk are also contaminated 
with these residues. The highest levels of glyphosate are found in grain and sugar crops. The herbicide 
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is not only used with RR crops, but also, as previously mentioned, it is used as a preharvest desiccant 
on sugar cane, wheat and also RR sugar beets, canola, and cottonseed for oils, among others. 
It is difficult to get information on actual amounts of glyphosate present in foods, due to the 
perception that it is nontoxic to humans [1,6]. The USDA Pesticide Data Program (PDP) is a voluntary 
program which randomly monitors agricultural chemical residues in the food supply. A search of the 
most recent data for 2010, published in May 2012, found statistics for the most popular agricultural 
chemicals except for glyphosate and glufosinate, another organophosphate. Residue data for the most 
popular herbicide on the planet were not available, but, interestingly, information on atrazine and other 
herbicides were readily available. Communication with USDA revealed that no data were available 
due to lack of monitoring. However, in 2013, for the first time, the USDA will be releasing a small 
amount of data for glyphosate residues only in soy. Lack of program funding was cited as the reason 
for this lack of data. 
 Recently, residue levels have been on the rise, due to higher rates and frequency of application, 
which in turn is due to increasing weed resistance. This has led the chemical and biotech industry to 
demand approvals for higher residue standards. In 1999 both the European Union (EU) and the UK 
raised the maximal glyphosate levels allowed in soy for industry from 0.1 ppm to 20 ppm. Both the 
USA and Argentina supply glyphosate-laden grains to European markets, so one could expect to find 
similar levels in the U.S. 
The European Union’s current standard for glyphosate in lentils is 0.1 mg/kg but a new industry 
proposal seeks to raise the standard by more than 100 times to 10 mg/kg or even 15 mg/kg [276]. This 
is not due to safety considerations, but rather to levels that are anticipated, following usage of the 
herbicide as a preharvest desiccant. The action will ignore the possible effects to public health. The 
effects of animal health from ingestion of glyphosate residues have also been ignored. Current 
standards for residues in feed and forage materials are totally out of line with those of humans. 
Tolerances for animal grass and corn forage are 300 and 400 ppm respectively. It is apparent that the 
EPA standard is being ignored on a global scale for industry at the expense of public health and  
the environment. 
13. Discussion 
Glyphosate is today the most popular herbicide in use in agricultural practices in the U.S., and, 
increasingly, throughout the world. Its usage rate has accelerated significantly in the last decade due 
mainly to two factors: (1) the patent expiration in 2000 led to greatly reduced cost, and (2) the adoption 
of genetically modified crops that are resistant to its toxic effects allows for higher exposure with little 
loss in harvest yield. The notion that glyphosate has minimal toxicity in humans, widely popularized by 
Monsanto, has prevented farmers from using caution in their application of this chemical to their crops. 
The recent rise in the rates of autism diagnoses in the United States is a cause for alarm. We have 
recently proposed that autism can be characterized as a chronic low-grade encephalopathy, where the 
cascade of events taking place in the brain is a process that enables the renewal of severely depleted 
sulfate supplies to the brain [277]. We identified a dysbiosis in the gut as a source of ammonia that 
initiates the encephalytic response, and we proposed glyphosate as one of the many environmental 
toxins that might be responsible for the dysbiosis and for sulfate depletion. A review of the literature 
Entropy 2013, 15 1443 
 
 
on glyphosate has confirmed our suspicions that glyphosate might play a role, and, further, have led us 
to believe that glyphosate may be the most significant environmental toxin contributing to autism. 
While it is pervasive in our food supply, the fact that it is deemed by most regulators to be nontoxic 
makes it especially insidious. The key pathological biological effects of glyphosate -- disruption of the 
gut bacteria, impairment of sulfate transport, and interference with CYP enzyme activity—can easily 
explain the features that are characteristic of autism. 
The term "developmental immunotoxicity" has been coined to describe permanent modifications to 
the immune function that take place early in life, leading to later development of allergies, asthma, and 
autoimmune diseases [278–280]. These authors have argued that prenatal and/or early life exposure to 
environmental toxins can lead to a phenotype that includes a hyperinflammatory response and 
disruption of cytokine networks, and they propose that an increased exposure to environmental toxins 
early in life may contribute to the increased incidence of these conditions observed today. It is 
significant that these problems often occur in association with autism [281]. 
Contrary to the current widely-held misconception that glyphosate is relatively harmless to humans, 
the available evidence shows that glyphosate may rather be the most important factor in the 
development of multiple chronic diseases and conditions that have become prevalent in Westernized 
societies. In addition to autism, these include gastrointestinal issues such as inflammatory bowel 
disease, chronic diarrhea, colitis and Crohn’s disease, obesity, cardiovascular disease, depression, 
cancer, cachexia, Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, and ALS, among others. 
While glyphosate is obviously not the only environmental toxin to contribute to these diseases and 
conditions, glyphosate’s ability to disrupt the gut bacteria, to impair serum transport of sulfate and 
phosphate, and to interfere with CYP enzymes, logically progresses to this multitude of diseased states, 
through well-established biological processes. And glyphosate’s disruption of the body’s ability to 
detoxify other environmental toxins leads to synergistic enhancement of toxicity. While genetics surely 
play a role in susceptibility, genetics may rather influence which of these conditions develops in the 
context of glyphosate exposure, rather than whether any of these conditions develops. 
We have explained the logical sequence of events leading to serotonin deficiency and subsequent 
pathologies, following glyphosate’s disruption of tryptophan synthesis by gut bacteria [10,29], and its 
further sequestration into macrophages that infiltrate the intestinal tissues in order to detoxify 
lipopolysaccharides released from pathogenic bacteria, whose overgrowth is induced by glyphosate [35]. 
Sulfate depletion arises in the gut, both because of impaired transport of free sulfate in the bloodstream 
and impaired sulfate synthesis by eNOS [63,64]. Disruption of gut bacteria, exposure to toxic phenolic 
compounds necessary to enable sulfate transport, and deficient sulfate supply to the 
mucopolysaccharides in the gut all contribute to the leaky gut syndrome that is a common feature in 
autism [51]. The evidence shows that glyphosate can interfere with development through its 
suppression of aromatase synthesis [110] and through its interference with the breakdown of retinoic 
acid [113] and its interference with CDKs and sulfate supplies. Glyphosate could also be a factor in the 
current epidemic in vitamin D3 deficiency [166] through its disruption of the CYP enzymes that 
activate this hormone in the liver [164,165]. The kosmotropic property of the glyphosate molecule 
combined with its disruption of CYP enzymes in the blood stream can lead to excess thrombosis and 
hemorrhaging, common problems today among the elderly. 
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We propose that glyphosate’s disruption of the synthesis of sulfate by the CYP orphan enzyme, 
eNOS, leads to widespread deficiencies in cholesterol and sulfate in the blood stream and all the 
tissues. We have previously described how disruption of eNOS’ synthesis of sulfate would lead to 
diabetes and cardiovascular disease [177]. Glyphosate’s induction of excess synthesis of ammonia in 
the gut, combined with depletion of zinc through impaired absorption, depletion of serotonin through 
dysbiosis of its substrate, tryptophan, depletion of dopamine through impaired synthesis of its 
substrate, tyrosine, depletion of vitamin D3, due to impairments in the CYP enzyme responsible for its 
activation, and depletion of sulfate through interference with its synthesis, can all lead to a multitude of 
pathologies in the brain, including autism, Alzheimer’s disease, ADHD, Parkinson’s disease, multiple 
sclerosis and ALS. 
There is a substantial alignment among countries, worldwide, with low or decreasing birth rates, 
emerging obesity problems, and an increasing glyphosate burden. Given the arguments presented here, 
it is plausible that glyphosate is causal in these trends. It may also be possible to demonstrate strong 
correlations between glyphosate usage and both autism and breast cancer. Formal epidemiological 
studies should be conducted to look at these issues more closely. 
In our opinion, it is imperative that governments around the globe unite in investing significant 
research funds to support independent studies evaluating the long-term effects of glyphosate. Other 
researchers should try to reproduce the results obtained in [9] showing tumorigenesis and premature 
death in rats with life-long exposure to glyphosate. The study on the gut microbiome of chickens [35] 
needs to be reproduced in other species, and the gene array study on E. coli [39] needs to be 
reproduced for other common gut bacteria. The novel idea that glyphosate disrupts sulfate transport 
through its kosmotropic effects, as predicted given biophysical laws, needs to be verified in specific 
studies among a variety of species. This could be done by comparing the levels of free sulfate in the 
blood under conditions of glyphosate exposure against controls. The study on glyphosate's effects on 
bees [126] should be reproduced by other researchers, along with further studies examining the impact 
of prior exposure to glyphosate on bees' resistance to pesticides. More refined and economical methods 
for detecting glyphosate in the food supply, such as in [0,283], and in the water supply [284], need to 
be developed, and then applied to a variety of different food items. Most critical in our view are the 
vegetable oils derived from GM crops  canola oil, soybean oil, corn oil, and cottonseed oil, as well as 
soy-derived protein, beet sugar, and high fructose corn syrup – ingredients that are pervasive in 
processed foods. Glyphosate is likely also present in meat, eggs, cheese, and other dairy products 
derived from animals fed glyphosate-contaminated grass, alfalfa, corn, and soy [285,286]. 
14. Conclusion 
This paper presents an exhaustive review of the toxic effects of the herbicide, glyphosate, the active 
ingredient in Roundup®, in humans, and demonstrates how glyphosate’s adverse effects on the gut 
microbiota, in conjunction with its established ability to inhibit the activity of cytochrome P450 
enzymes, and its likely impairment of sulfate transport, can remarkably explain a great number of the 
diseases and conditions that are prevalent in the modern industrialized world. Its effects are insidious, 
because the long-term effects are often not immediately apparent. The pathologies to which glyphosate 
could plausibly contribute, through its known biosemiotic effects, include inflammatory bowel disease, 
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obesity, depression, ADHD, autism, Alzheimer’s disease, Parkinson’s disease, ALS, multiple sclerosis, 
cancer, cachexia, infertility, and developmental malformations. Glyphosate works synergistically with 
other factors, such as insufficient sun exposure, dietary deficiencies in critical nutrients such as sulfur 
and zinc, and synergistic exposure to other xenobiotics whose detoxification is impaired by glyphosate. 
Given the known toxic effects of glyphosate reviewed here and the plausibility that they are negatively 
impacting health worldwide, it is imperative for more independent research to take place to validate 
the ideas presented here, and to take immediate action, if they are verified, to drastically curtail the use 
of glyphosate in agriculture. Glyphosate is likely to be pervasive in our food supply, and, contrary to 
being essentially nontoxic, it may in fact be the most biologically disruptive chemical in our environment. 
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